You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Necitumumab

Showing 1 - 24 of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Small Cell Lung Carcinoma Trial in Duarte, Stanford, Nashville (drug, biological, other)

Terminated
  • Non-Small Cell Lung Carcinoma
  • Duarte, California
  • +2 more
Apr 6, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Duarte, California
  • +14 more
Jan 27, 2023

Metastatic Lung Non-Small Cell Carcinoma, Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer American Joint

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +4 more
  • Necitumumab
  • +4 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jan 5, 2023

Carcinoma, NSCLC (NSCLC) Trial in Orlando (Necitumumab, Nab-Paclitaxel, Carboplatin)

Completed
Has Results
  • Carcinoma, Non-Small Cell Lung Cancer (NSCLC)
  • Necitumumab
  • +2 more
  • Orlando, Florida
    Florida Hospital Cancer Institute
Oct 30, 2020

Solid Tumor, Adult Trial in Germany, Italy, Spain (First part: Gatipotuzumab and Tomuzotuximab; Second part: Gatipotuzumab and

Completed
  • Solid Tumor, Adult
  • First part: Gatipotuzumab and Tomuzotuximab; Second part: Gatipotuzumab and Tomuzotuximab or anti-EGFR antibody (Cetuximab, Panitumumab or Necitumumab)
  • Berlin, Germany
  • +3 more
Jul 7, 2021

Non Small Cell Lung Cancer Trial in Worldwide (Pemetrexed, Cisplatin, Necitumumab)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • Nyack, New York
  • +100 more
Dec 12, 2021

Squamous Cell Lung Cancer Trial in Bronx (Necitumumab-Gemcitabine-Cisplatin, Evaluation to determine if patient is a candidate

Terminated
Has Results
  • Squamous Cell Lung Cancer
  • Bronx, New York
    Montefiore Medical Center
Mar 3, 2020

Non Small Cell Lung Cancer Trial in Worldwide (Necitumumab, Gemcitabine, Cisplatin)

Active, not recruiting
Has Results
  • Non Small Cell Lung Cancer
  • Necitumumab
  • +2 more
  • Chandler, Arizona
  • +181 more
Feb 4, 2022

NSCLC Trial in Worldwide (Osimertinib, Savolitinib, Gefitinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Duarte, California
  • +52 more
Jan 19, 2023

Stage IV NSCLC Trial in Worldwide (Necitumumab, Pembrolizumab)

Completed
Has Results
  • Stage IV Non-Small Cell Lung Cancer
  • Fort Myers, Florida
  • +15 more
Sep 11, 2020

Squamous Cell Carcinoma Trial in El Segundo (drug, biological, procedure)

Unknown status
  • Squamous Cell Carcinoma
  • Aldoxorubicin HCl
  • +20 more
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Aug 10, 2020

NSCLC, Tumor Metastasis Trial in Belgium, France, Spain (Necitumumab, Abemaciclib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Neoplasm Metastasis
  • Charleroi, Belgium
  • +14 more
Jun 26, 2020

Malignant Solid Tumor Trial in United States (Necitumumab, Gemcitabine, Cisplatin)

Completed
Has Results
  • Malignant Solid Tumor
  • Necitumumab
  • +2 more
  • Scottsdale, Arizona
  • +3 more
Sep 10, 2019

Squamous NSCLC Trial in Japan (Necitumumab, Gemcitabine, Cisplatin)

Completed
Has Results
  • Squamous Non-small Cell Lung Cancer
  • Necitumumab
  • +2 more
  • Aichi, Japan
  • +19 more
Oct 11, 2019

Locally Advanced Squamous NSCLC, Metastatic Squamous NSCLC Trial in Worldwide (Necitumumab, Gemcitabine, Carboplatin)

Withdrawn
  • Locally Advanced Squamous Non-Small Cell Lung Cancer
  • Metastatic Squamous Non-Small Cell Lung Cancer
  • Necitumumab
  • +2 more
  • Edina, Minnesota
  • +18 more
Sep 25, 2019

Cancer Target Therapy Efficacy

Active, not recruiting
  • Cancer
  • RNA sequencing
  • +5 more
  • Walnut, California
  • +6 more
Sep 13, 2021

Squamous Non Small Cell Lung Cancer Trial in Worldwide (Necitumumab, Paclitaxel, Carboplatin)

Completed
Has Results
  • Squamous Non Small Cell Lung Cancer
  • Necitumumab
  • +2 more
  • Jonesboro, Arkansas
  • +50 more
Sep 5, 2019

Squamous NSCLC Trial in Italy (Nivolumab 10 MG/ML Intravenous Solution, Best Supportive Care)

Active, not recruiting
  • Squamous Non-small Cell Lung Cancer
  • Nivolumab 10 MG/ML Intravenous Solution
  • Best Supportive Care
  • Imola, Bologna, Italy
  • +30 more
Sep 30, 2022

NSCLC, Cardiovascular Complication Trial in Guangzhou (Multiple cardiovascular drugs related to "Golden Triangle")

Recruiting
  • Non-small Cell Lung Cancer
  • Cardiovascular Complication
  • Multiple cardiovascular drugs related to "Golden Triangle"
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Jul 24, 2021

Tumors Trial in Tokyo (IMC-11F8)

Completed
Has Results
  • Neoplasms
  • IMC-11F8
  • Tokyo, Japan
    ImClone Investigational Site
Dec 9, 2016

Solid Tumors Trial in United States (Necitumumab)

Completed
Has Results
  • Solid Tumors
  • Necitumumab
  • Ann Arbor, Michigan
  • +7 more
Jun 13, 2016

Metastatic Colorectal Cancer Trial in Belgium, Spain (IMC-11F8 (necitumumab), Oxaliplatin, Folinic acid (FA))

Completed
Has Results
  • Metastatic Colorectal Cancer
  • IMC-11F8 (necitumumab)
  • +3 more
  • Brussels, Belgium
  • +4 more
Dec 21, 2015

NSCLC Trial in Worldwide (Necitumumab, Gemcitabine, Cisplatin)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Necitumumab
  • +2 more
  • Birmingham, Alabama
  • +16 more
May 20, 2016

Solid Tumors Trial in Amsterdam, Utrecht (IMC-11F8, IMC-11F8 I.V.)

Completed
  • Solid Tumors
  • IMC-11F8
  • IMC-11F8 I.V.
  • Amsterdam, Netherlands
  • +1 more
Oct 11, 2010